Aid Cuts Threaten Malaria Vaccine Rollout in Africa

Vaccine Success Meets Funding Crisis

New malaria vaccines have significantly reduced child mortality in Ghana, but a severe funding shortfall at Gavi, the vaccine alliance, threatens wider rollout across Africa. Aid cutbacks from key donors, including the United States and Britain, have created a substantial budget gap, potentially leading to thousands of preventable deaths.

Program Overview and Achievements

Ghana has seen remarkable progress, with confirmed deaths in children under five dropping nearly 86 percent since the introduction of new vaccines from GSK and Oxford University. Gavi is currently the sole organization purchasing these vaccines for African nations. The program's success demonstrates the potential to combat a disease that kills nearly half a million young children in Africa annually.

Impact of Aid Reductions

Gavi faces a $2.9 billion shortfall for its overall funding period, leaving its malaria program with 28 percent less than the expected need. This gap is a direct result of reduced contributions, including the US ceasing support and Britain cutting its pledge by over 20 percent. Internal estimates project these cuts could result in an additional 19,000 child deaths due to lower vaccination rates.

Conclusion and Outlook

The effectiveness of new malaria vaccines is proven, but their deployment is now constrained by financial resources. While some countries are seeking to self-fund, others like Tanzania are forced to delay their campaigns. The future of the program hinges on securing new funding to bridge the gap between the vaccines' promise and their availability.

FAQ

Q: Why is there a funding shortfall for the malaria vaccine program?
A: Key donors to Gavi, the vaccine alliance, including the United States and the United Kingdom, have significantly reduced their financial contributions.

Q: What is the potential human cost of these funding cuts?
A: Gavi estimates the budget shortfall could lead to 19,000 additional child deaths from malaria over the next five years due to reduced vaccine access.

Q: How effective have the new malaria vaccines been?
A: In pilot programs in Ghana, the vaccines contributed to a nearly 86 percent reduction in confirmed malaria deaths among children under five from 2018 to 2024.

Source: Reuters via Investing.com